Rephonic
Artwork for The Readout Loud

The Readout Loud

STAT
FDA
Eli Lilly
Novo Nordisk
Biotechnology
Pfizer
Gene Therapy
Covid-19
Duchenne Muscular Dystrophy
CRISPR
RFK Jr.
Vertex Pharmaceuticals
Sarepta Therapeutics
Moderna
Drug Pricing
Biotech
Biotech Industry
Obesity
Astrazeneca
Obesity Drugs
Glp-1

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

PublishesWeeklyEpisodes421Founded9 years ago
Number of ListenersCategory
Business

Listen to this Podcast

Artwork for The Readout Loud

Latest Episodes

How has the National Institutes of Health been spending its budget? Why are biotech investors feeling gloomy? And what is the most quintessential Boston movie?

We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech... more

On this week’s episode of "The Readout LOUD": Why have so many Americans lost trust in science? And how have our policy leaders fueled that mistrust? We speak to STAT’s new trust-in-science reporter Nicholas Florko about the impact of Americans’ grow... more

"The Readout LOUD" is going international this week.

STAT's Jason Mast joins the podcast from Shanghai, where he's digging into what the rise of Chinese drug development means for the biotech industry. The hosts also speak to colleague Margaret Mant... more

International researchers got a reprieve in the courts this week. But many are still considering leaving the states for opportunities elsewhere. What does that mean for the future of American medical research?

We discuss that, plus the latest news i... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Ground Truths
Ground TruthsEric Topol

Recent Guests

Margaret Manto
STAT's new FDA reporter
STAT
Episode: The FDA's Overton era, and dispatches from Shanghai
Fanta Av
Executive director of Nafsa, Association of International Educators
NAFSA
Episode: Definium's new psychedelics data, and a reprieve for international scientists
Ethan Weiss
Cardiologist at UCSF; co-founder and chief scientific officer at Rhea Therapeutics
UCSF, Rhea Therapeutics
Episode: Why two promising heart drugs flopped and what's next
Jared Baitin
Senior Vice President, Clinical Development and Virology Therapeutic Head at Gilead
Gilead
Episode: 411: Capricor's data clash and a fugitive in the C-suite
Matthew Herper
Colleague and author of the Grace piece
STAT
Episode: 410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing
Matt Wilsey
Father (Grace's father), CEO of Grace Science
Grace Science
Episode: 410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing
Jonathan Kimmelman
Bioethicist at McGill University
McGill University
Episode: 409: Predicting biotech clinical trials & a new Alzheimer's drug controversy
Chris Deacon
Attorney; whistleblower whistleblower advocate who exposed overpayments in New Jersey health coverage
Independent
Episode: 408: Whistleblower takes on health insurance and FDA commissioner candidates
Mika Kakafuda-Durink
Senior Vice President, Therapeutic Area Head Oncology
Gilead Sciences
Episode: 407: The mysterious case of Eli Lilly's obesity drug

Hosts

Allison DeAngelis
Host of The Readout Loud
Adam Feuerstein
Host of The Readout Loud
Elaine Chen
Co-host, analyst / Co-host

Reviews

4.7 out of 5 stars from 596 ratings
  • Constructive Feedback on Episode 398

    Hey STAT Team - As a long time reader and biotech CEO, I wanted to pass on hopefully constructive feedback on your show in general and this specific episode. I really enjoyed hearing the inside scoop from Bryan Roberts on Kelonia and the Lilly deal. That was great. Please do more of that! In the constructive feedback category, the one thing that I would caution you on, both in this episode and others, is the trivial nature (joking, in fact) in how you handle very, very tough times for these comp... more

    Apple Podcasts
    3
    DP75007
    United States5 months ago
  • David Olson

    Thoughtful and concise discussion about drug development processes. I found this illuminating

    and hopeful

    Apple Podcasts
    5
    Auldkirk
    United Kingdom10 months ago
  • Really informative and relevant

    Great coverage by the three hosts.

    Only area of improvement is if the audio editor can adjust the volume for all speakers to be equal because for some reason Elaine’s mic tends to be the loudest and I have to keep adjusting the volume for each speaker.

    Apple Podcasts
    4
    orange03$592
    United States10 months ago
  • Great pod!

    This is a great overview of the biopharm space with an engaging and fun style. I also like the unrelated chat amongst the team, particularly as a fellow fan of the Great British Bake Off, given this is an industry that can often take itself very seriously!

    Apple Podcasts
    5
    123etcetc
    United Kingdoma year ago
  • Please reboot the old quality bar

    This podcast was a gold mine a few years back. Really miss that run you had. Adam is good but even he was better back when surrounded with higher caliber cohosts.

    Apple Podcasts
    3
    freedomtochoose
    United Statesa year ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners praise real-world patient perspectives and regulatory context as differentiators
Some critics request more neutral tone and less perceived bias in coverage
Listeners appreciate the industry-savvy take on biotech news and the depth of interviews
Many reviews note strong informative value but suggest dialing back on in-jokes and casual banter

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#166
Ireland/Business
Apple Podcasts
#193
Israel/Business

Talking Points

Recent interactions between the hosts and their guests.

The FDA's Overton era, and dispatches from Shanghai
Q: Who is Heidi Overton and why is she a notable nominee for the FDA?
Margaret explains Overton's background as a preventive medicine physician with White House and domestic policy experience, and describes how her selection is seen as a stabilizing move after leadership turmoil, though her alignment with the MAHA movement raises questions about pace and policy direction.
Definium's new psychedelics data, and a reprieve for international scientists
Q: What comes next for the Nafsa-led lawsuit and the administration's ongoing efforts to limit international scientists?
She outlined that the injunction paused the rule for now, the lawsuit will continue, and they anticipate an appeal while pursuing the broader complaint, stressing that the stakes are long-term for US scientific leadership.
Definium's new psychedelics data, and a reprieve for international scientists
Q: Dr. Av, what do you see as wrong with the proposed four-year duration cap on student status?
She argued that the rule is unnecessary given existing tracking systems, would arbitrarily force many PhD students to seek extensions, and would threaten decades of established systems without solid evidence of widespread fraud.
Definium's new psychedelics data, and a reprieve for international scientists
Q: Jonathan, how big of a role do international students play in the biomedical research that happens in the US?
He explained that they constitute a substantial portion of the workforce, with around a quarter of graduate students in life sciences and about 60% of post-docs from overseas, highlighting the central role these researchers play in labs across the country.
409: Predicting biotech clinical trials & a new Alzheimer's drug controversy
Q: What are the main ethical concerns Jonathan Kimmelman raises about prediction markets in trials, and how might Kalshi mitigate them?
Kimmelman highlights risks to enrollment, bias in endpoints, and the need to stage rollout so markets don't influence ongoing data collection. He suggests limiting markets to later stages or post-data collection points and emphasizes maintaining trial integrity as a core priority.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Readout Loud

What is The Readout Loud about and what kind of topics does it cover?

Biotech-focused weekly briefing that explains the latest industry news, policy shifts, and clinical developments with a mix of sharp analysis, investigative context, and guest conversations. Episodes commonly pair regulatory updates (FDA leadership, approval dynamics, policy impacts) with behind-the-scenes industry moves (M&A, financing, and innovation pipelines), often weaving in patient perspectives and ethical considerations. A standout feature is the frequent, in-depth interviews with CEOs, scientists, and policy experts, alongside detailed discussions of real-world implications for patients, payers, and developers. This blend makes it useful for listeners who want fast, informed takes on where biotech and pharma are headed, and for pot... more

Where can I find podcast stats for The Readout Loud?

Rephonic provides a wide range of podcast stats for The Readout Loud. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Readout Loud and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Readout Loud get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for The Readout Loud, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Readout Loud?

Rephonic provides comprehensive predictive audience data for The Readout Loud, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Readout Loud have?

To see how many followers or subscribers The Readout Loud has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Readout Loud?

These podcasts share a similar audience with The Readout Loud:

1. BioCentury This Week
2. Biotech Hangout
3. The Long Run with Luke Timmerman
4. Ground Truths
5. Business Of Biotech

How many episodes of The Readout Loud are there?

The Readout Loud launched 9 years ago and published 421 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Readout Loud?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Readout Loud?

Rephonic pulls ratings and reviews for The Readout Loud from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Readout Loud?

Rephonic provides full transcripts for episodes of The Readout Loud. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Readout Loud?

Recent guests on The Readout Loud include:

1. Margaret Manto
2. Fanta Av
3. Ethan Weiss
4. Jared Baitin
5. Matthew Herper
6. Matt Wilsey
7. Jonathan Kimmelman
8. Chris Deacon

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days